78.09
-0.19%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in CNY, from our data supplier.
Revenue
CN¥1.86bn
FY2016FY2025
Net income
CN¥209.9m
FY2016FY2025
Free cash flow
−CN¥1.01bn
FY2016FY2025
Shareholders' equity
CN¥4.98bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥1.86bn | CN¥1.33bn | CN¥1.15bn | CN¥918.1m | CN¥552.0m | CN¥412.2m | CN¥321.7m | CN¥291.5m | CN¥219.9m | CN¥166.3m |
| Research and development | CN¥241.6m | CN¥211.3m | CN¥183.5m | CN¥162.6m | CN¥114.2m | CN¥68.2m | CN¥42.0m | CN¥25.6m | CN¥23.3m | CN¥15.1m |
| Operating income | CN¥255.6m | CN¥88.5m | CN¥105.1m | CN¥58.5m | −CN¥84.4m | CN¥87.7m | CN¥62.2m | CN¥59.3m | CN¥37.9m | CN¥32.4m |
| Net income | CN¥209.9m | CN¥104.4m | CN¥110.2m | CN¥79.5m | −CN¥53.3m | CN¥86.7m | CN¥74.3m | CN¥57.2m | CN¥34.3m | CN¥31.3m |
| Diluted earnings per share | 0.78 | 0.36 | 0.41 | 0.30 | -0.25 | 0.42 | 0.33 | 0.36 | 0.13 | 0.12 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | CN¥8.67bn | CN¥7.29bn | CN¥6.57bn | CN¥3.03bn | CN¥2.11bn | CN¥1.68bn | CN¥1.48bn | CN¥839.7m | CN¥598.8m | CN¥487.1m |
| Cash and short-term investments | — | CN¥2.19bn | CN¥3.16bn | CN¥292.1m | CN¥186.1m | CN¥401.8m | CN¥185.4m | CN¥56.7m | CN¥84.9m | CN¥82.9m |
| Total liabilities | CN¥3.69bn | CN¥2.47bn | CN¥1.80bn | CN¥1.50bn | CN¥820.3m | CN¥517.0m | CN¥403.3m | CN¥437.6m | CN¥255.2m | CN¥180.3m |
| Debt | CN¥622.0m | CN¥897.3m | CN¥793.0m | CN¥546.2m | CN¥199.4m | CN¥105.5m | CN¥142.3m | CN¥155.3m | CN¥25.1m | CN¥21.6m |
| Shareholders' equity | CN¥4.98bn | CN¥4.82bn | CN¥4.77bn | CN¥1.53bn | CN¥1.29bn | CN¥1.16bn | CN¥1.07bn | CN¥395.6m | CN¥338.0m | CN¥302.8m |
| Shares outstanding | 268m | 293m | 269m | 267m | 215m | 208m | 222m | 161m | 268m | 268m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | CN¥238.7m | CN¥346.2m | −CN¥130.6m | −CN¥107.5m | CN¥27.5m | CN¥91.1m | CN¥43.9m | −CN¥31.9m | CN¥26.4m | −CN¥10.9m |
| Capital spending | −CN¥1.25bn | −CN¥1.49bn | −CN¥270.8m | −CN¥170.1m | −CN¥318.8m | −CN¥284.0m | −CN¥41.9m | −CN¥107.0m | −CN¥89.3m | −CN¥74.7m |
| Free cash flow | −CN¥1.01bn | −CN¥1.14bn | −CN¥401.5m | −CN¥277.6m | −CN¥291.3m | −CN¥192.9m | CN¥2.0m | −CN¥138.9m | −CN¥62.9m | −CN¥85.6m |
| Dividends paid | −CN¥54.2m | −CN¥46.3m | −CN¥33.1m | −CN¥11.0m | −CN¥8.7m | −CN¥7.5m | −CN¥8.0m | −CN¥6.3m | −CN¥1.2m | −CN¥2.5m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥444.1m | CN¥325.9m | CN¥702.2m | CN¥493.8m | CN¥439.9m | CN¥227.0m | CN¥593.9m | CN¥223.5m |
| Operating income | CN¥68.1m | CN¥7.9m | CN¥75.0m | CN¥84.2m | CN¥91.7m | −CN¥30.1m | CN¥92.4m | −CN¥36.3m |
| Net income | CN¥34.4m | CN¥16.8m | CN¥54.2m | CN¥79.4m | CN¥91.3m | −CN¥15.0m | CN¥77.7m | −CN¥22.9m |
| Diluted earnings per share | 0.13 | 0.06 | 0.20 | 0.30 | 0.34 | -0.06 | 0.26 | -0.08 |
| Cash from operations | — | — | — | CN¥106.0m | −CN¥170.0m | −CN¥122.0m | — | CN¥46.0m |
| Capital spending | −CN¥419.0m | −CN¥152.0m | −CN¥435.0m | −CN¥359.0m | −CN¥294.0m | −CN¥154.0m | −CN¥817.0m | −CN¥312.0m |
| Free cash flow | — | — | — | −CN¥253.0m | −CN¥464.0m | −CN¥276.0m | — | −CN¥266.0m |
| Total assets | CN¥9.20bn | CN¥8.99bn | CN¥8.67bn | CN¥8.60bn | CN¥8.17bn | CN¥7.69bn | CN¥7.29bn | CN¥6.93bn |
| Cash and short-term investments | — | — | — | CN¥1.69bn | CN¥1.76bn | CN¥2.03bn | CN¥2.19bn | CN¥2.37bn |
| Debt | CN¥597.5m | CN¥651.6m | CN¥622.0m | CN¥1.27bn | CN¥1.30bn | CN¥1.09bn | CN¥890.5m | CN¥790.0m |
| Shareholders' equity | CN¥5.24bn | CN¥5.00bn | CN¥4.98bn | CN¥4.93bn | CN¥4.86bn | CN¥4.77bn | CN¥4.82bn | CN¥4.81bn |
Financial ratios
Data as of 23 Sept 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Operating margin | 13.7% | 6.7% | 9.1% | 6.4% | -15.3% | 21.3% |
| Net margin | 11.3% | 7.9% | 9.6% | 8.7% | -9.7% | 21.0% |
| Return on equity | 4.2% | 2.2% | 2.3% | 5.2% | -4.1% | 7.5% |
| Return on assets | 2.4% | 1.4% | 1.7% | 2.6% | -2.5% | 5.2% |
| Free cash flow yield | 4.9% | 5.5% | 0.5% | 0.2% | 1.4% | 1.6% |
| Revenue growth | 40.5% | 15.0% | 25.5% | 66.3% | 33.9% | 28.1% |
| Earnings growth | 101.0% | -5.3% | 38.7% | -249.1% | -161.5% | 16.7% |
| Current ratio | 1.67x | 2.31x | 3.45x | 1.38x | 1.99x | 4.11x |
| Debt to equity | 0.12x | 0.18x | 0.16x | 0.35x | 0.14x | 0.09x |
| Equity ratio | 57.5% | 66.1% | 72.6% | 50.4% | 61.1% | 69.2% |
| Interest coverage | 10.60x | 4.70x | 4.25x | 4.46x | -12.56x | 14.78x |
| R&D as a share of sales | 13.0% | 15.9% | 15.9% | 17.7% | 20.7% | 16.6% |
| Buybacks as a share of market value | 8.7% | -9.0% | -0.9% | -24.2% | -3.3% | 6.2% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 26.6% | 35.2% | — |
| Operating income | 63.5% | 23.9% | — |
| Net income | 38.2% | 19.3% | — |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Price to earnings | 142.3 | 110.8 | 202.2 | 244.4 | -312.9 | 132.8 | 60.1 |
| Price to sales | 16.3 | 8.8 | 19.8 | 21.5 | 30.6 | 28.4 | 14.3 |
Dividends and splits
Per share, in the currency the company pays
Paid for 3 years. Last went ex-dividend on 16 Sept 2026.
| FY2026 | FY2025 | FY2024 | FY2023 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Paid in the year | 0.11 | 0.112 | 0.104 | 0.036 | 0.04 | 0.034 |
- 7-for-5 split · 14 May 2024
- 7-for-5 split · 15 May 2023
- 7-for-5 split · 28 Sept 2022
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.